Jie-wei Luo
Impact in
Papers in
-
- Ion channel regulation and function 4
- RNA Research and Splicing 3
-
- Prostate Cancer Diagnosis and Treatment 4
- Medical Imaging and Pathology Studies 3
- Co-authors
- Jianbin Huang (4 shared papers)Xing Lin (3 shared papers)Jin Zhao (1 shared paper)Jingjing Li (1 shared paper)Dan‐dan Ruan (30 shared papers)Hanlu Wang (10 shared papers)Zhu-ting Fang (24 shared papers)Jianhui Zhang (18 shared papers)
- Journals
- Abdominal Radiology (4 papers)Frontiers in Cardiovascular Medicine (4 papers)Scientific Reports (2 papers)Bioorganic Chemistry (2 papers)Angewandte Chemie International Edition (2 papers)
- Partner nations
- ChinaSouth Korea
In The Last Decade
Jie-wei Luo
57 papers receiving 305 citations
Peers
Comparison fields: 5 of 82
- Nephrology 21
- Complementary and alternative medicine 21
- Cancer Research 33
- Cardiology and Cardiovascular Medicine 49
- Molecular Biology 122
Countries citing papers authored by Jie-wei Luo
This map shows the geographic impact of Jie-wei Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie-wei Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie-wei Luo more than expected).
Fields of papers citing papers by Jie-wei Luo
This network shows the impact of papers produced by Jie-wei Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie-wei Luo. The network helps show where Jie-wei Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Jie-wei Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 62 | |
| 2 | 2023 | 19 | |
| 3 | Differences in gut microbiota structure in patients with stages 4-5 chronic kidney disease. | 2021 | 15 |
| 4 | 2019 | 14 | |
| 5 | 2023 | 11 | |
| 6 | 2018 | 11 | |
| 7 | 2016 | 9 | |
| 8 | 2018 | 9 | |
| 9 | 2023 | 8 | |
| 10 | 2022 | 8 | |
| 11 | 2025 | 7 | |
| 12 | 2022 | 7 | |
| 13 | Oxymatrine inhibits the development of non-small cell lung cancer through miR-367-3p upregulation and target gene SGK3 downregulation. | 2020 | 7 |
| 14 | 2020 | 6 | |
| 15 | 2023 | 6 | |
| 16 | 2021 | 6 | |
| 17 | 2020 | 5 | |
| 18 | 2022 | 5 | |
| 19 | 2021 | 5 | |
| 20 | 2018 | 5 |
About Jie-wei Luo
Jie-wei Luo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Rheumatology, Cardiology and Cardiovascular Medicine and Physiology, having authored 67 papers that have together received 307 indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (5 papers), Urologic and reproductive health conditions (4 papers), Nanoplatforms for cancer theranostics (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers), Ion channel regulation and function (4 papers), RNA Research and Splicing (3 papers), Medical Imaging and Pathology Studies (3 papers) and Diet and metabolism studies (3 papers). The work is most often cited by research in Nephrology (21 citations), Complementary and alternative medicine (21 citations), Cancer Research (33 citations), Cardiology and Cardiovascular Medicine (49 citations) and Molecular Biology (122 citations). Jie-wei Luo has collaborated with scholars based in China and South Korea. Frequent co-authors include Jianbin Huang, Xing Lin, Jin Zhao, Jingjing Li, Dan‐dan Ruan, Hanlu Wang, Zhu-ting Fang, Jianhui Zhang, Qiuyan Wu and Liu Gui. Their work appears in journals such as Abdominal Radiology, Frontiers in Cardiovascular Medicine, Scientific Reports, Bioorganic Chemistry and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.